Exact Sciences (EXAS) Tops Q2 EPS by 11c
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
UBAB, LOAN, FITB, More
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($0.94), $0.11 better than the analyst estimate of ($1.05). Revenue for the quarter came in at $522 million versus the consensus estimate of $497.18 million.
GUIDANCE:
Exact Sciences sees Q3 2022 revenue of $1.98-2.022 billion, versus the consensus of $2.02 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Fifth Third Bancorp (FITB) Misses Q2 EPS by 1c
- Cohen & Steers (CNS) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
